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Abstract
Background: Non-alcoholic steatohepatitis is a growing public health problem with no approved therapy; as cytokines 
and other pro-inflammatory mediators may each play a role in transition of  steatosis to NASH which is projected to be the 
leading cause of  liver transplantation in the United States by 2020. 
Objective: The aim of  this study was to compare the impact of  aerobic versus resisted exercise training on inflammatory 
cytokines and markers of  liver function in patients with nonalcoholic steatohepatitis. 
Material and Methods: Fifty patients with NASH were included in the study and divided into two subgroups. Participants 
were included into 2 equal groups; the first group (A) received aerobic exercise training. The second group (B) received 
resisted exercise training three times a week for 3 months.  
Results: The mean values of  TNF- α, IL6, IL8, ALT and AST were significantly decreased in group (A) and group (B).Also; 
there was a significant difference between both groups after treatment. 
Conclusion: Aerobic exercise training modulates inflammatory cytokine levels and markers of  liver function in patients with 
nonalcoholic steatohepatitis.




Non-alcoholics steatohepatitis (NASH) is a chronic 
progressive liver disease characterized by accumulation 
of  fat in the liver accompanied by necro-inflammation 
and hepatocellular injury [1, 2]. NASH prevalence is 
estimated between 2–3% respectively of  the general 
population in Western societies [3]. In all probability 
NASH prevalence figures will rise in the future as 
NASH is considered the hepatic manifestation of  the 
metabolic syndrome and the number of  overweighed 
individuals is growing. However, the exact mechanism 
of  the progression from a benign steatotic liver to an 
inflamed organ remains a point of  interest  as NASH is 
projected to be the leading cause of  liver transplantation 
in the United States by 2020 [4,5]. 
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Nonalcoholic steatohepatitis (NASH) is a liver disease 
characterized by diffuse fatty acid infiltration and 
inflammation. The exact cause of  NASH is unclear, but 
it is increasingly becoming more evident that the disease 
is much more common than was previously thought [6]. 
NASH is seen in patients of  all ages, including children, 
and is associated with over nutrition and under activity, 
insulin resistance, and genetic factors. Lipotoxicity, 
oxidative stress, cytokines, and other pro-inflammatory 
mediators may each play a role in transition of  steatosis 
to NASH [7, 8]. 
The pathogenesis of  NASH includes insulin resistance, 
increased inflammation, tumor necrosis factor-alpha 
(TNF-α), interleukin-6 (IL-6), interleukin-8 (IL-8) and 
increased oxidative damage [5, 9, 10]. In many cases, 
NASH causes asymptomatic elevation of  the level of  
liver transaminases. Alanine aminotransferase (ALT) is 
most closely related to liver fat accumulation, and it has 
been used as an indicator of  NASH [11]. Since liver 
biopsy cannot be performed as a screening method 
to detect NASH in general population, abdominal 
ultrasonography as a noninvasive modality has been 
widely used [12]. 
Two adipocyte-derived hormones, leptin and adiponec-
tin, have been implicated in the pathogenesis of  both 
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non-alcoholicsteatohepatitis and insulin resistance. In 
subjects with congenital lipodystrophy syndrome and 
low serum leptin concentrations, severe steatosis and 
insulin resistance have been reported [13]. Treatment 
of  these subjects with leptin reduced liver fat and liver 
enzyme abnormalities and improved insulin resistance. 
Low concentrations of  adiponectin have been associ-
ated with high visceral fat and have been implicated in 
the development of  the insulin resistance syndrome. 
Furthermore, in a study of  90 morbidly obese Chinese 
subjects, plasma concentrations of  adiponectin were in-
versely correlated with those of  ALT [14].  
Leptin induces the release of  pro-inflammatory 
cytokines such as TNF-α which amplifies the process 
[15].  If  the balance is not restored the protective 
mechanisms of  the adipose tissue become harmful and 
the body is entering a chronic inflammatory state, which 
is particularly seen in central obesity [16].   
Adiponectin protects from inflammation and fibrosis in 
metabolic liver disease. Adiponectin is an adipose tissue 
released protein which ameliorates insulin resistance, 
and thereby, may protect from NAFLD. However, 
systemic levels are reduced in these patients [17, 18].  In 
animal models of  non-alcoholicsteatohepatitis (NASH) 
adiponectin lowers inflammation, reactive oxygen 
species production and liver fibrosis and thereby, may 
protect from progressive liver disease [14, 19].  
Few studies have prospectively examined the effect of  
exercise on elevated levels of  inflammatory biomarkers 
in diabetic subjects and found contrasting results in 
terms of  efficacy and dependence on weight loss [20, 21]. 
The potential mechanisms for the anti-inflammatory 
effect of  exercise, including reduced percentage of  
body fat and macrophage accumulation in adipose 
tissue, muscle-released interleukin-6 inhibition of  tumor 
necrosis factor-a, and the cholinergic anti-inflammatory 
pathway [22].  
The aim of  this study was to compare the impact of  
aerobic versus resisted exercise training on inflammatory 




Fifty NASH patients (26 men, 24 women; mean age of  
51 ± 6 years) with body mass index (BMI) ranged from 
31 to 36 Kg/m2 , were selected from gastroenterology 
outpatient clinic, King Abdulaziz University Hospital, 
Jeddah, Saudi Arabia. Subjects were excluded if  they 
did not agree to participate, had a history of  diabetes 
mellitus, smoking, cardiovascular disease, had alcohol 
abuse problems , hepatic (i.e. infectious and viral 
disease) or renal disease, and if  they were being treated 
with antihyperlipidemic , antihypertensive or any 
antioxidants like vitamin C or E medications. Participants 
were included into 2 equal groups; the first group (A) 
included 13 men and 12 women who received moderate 
aerobic exercise training. The second group (B) included 
13 men and 12 women who received mild aerobic 
exercise training three times a week for 3 months.  The 
study was approved by the Ethics Committee of  King 
Abdulaziz University Hospital, Jeddah, Saudi Arabia 
and all patients gave informed consent for participation 
in this study. If  any adverse effects had occurred, the 
experiment would have been stopped. However, no 
adverse effects occurred, and so the data of  all the 
participants was available for analysis.
Each patient underwent abdominal US (Siemens 
Antares equipment with CH4-1 MHz transducer; 
Siemens Medical, Erlangen, Germany) in a fasting 
state. The presence of  hepatic steatosis was assessed 
independently by radiologists according to findings 
such as hepatorenal contrast, blurring of  the vascular 
wall, and profound attenuation of  the diaphragm. 
According to the findings of  ultrasound examination 
patient group with NASH was divided into three; as 
minimal, moderate and marked subgroup parallel to the 
increase in echogenicity [23].  
Laboratory analysis
Venous blood samples were collected in polystyrene 
tubes after a 12 hours fasting by venipuncture of  
the antecubital vein while patients rested in a supine 
position. The blood samples were transported to a 
laboratory within 1 hour and centrifuged at 4°C to 
remove serum. Serum ALT, AST levels were assayed 
using a Cobas Integra 800 analyzer (Roche Diagnostics, 
Geneve, Switzerland). While IL-6 levels were measured 
using “Immulite 2000” immunassay analyzer (Siemens 
Healthcare Diagnostics, Deerfield, USA). However, 
interleukin-8 (IL-8) and TNF-α levels were analyzed 
with ELISA kits using ELISA microplate strip washer 
(ELX 50), and ELISA microplate reader (ELX 808; 
BioTek Instruments, USA).
The aerobic exercise training program
Patients in Group A were submitted to a 40 min aerobic 
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session on a treadmill (the initial, 5-minute warm-up 
phase performed on the treadmill at a low load, each 
training session lasted 30 minutes and ended with 
5-minute recovery and relaxation phase) either walking 
or running, based on heart rate, until the target heart 
rate was reached, according to American College of  
Sport Medicine guidelines. The program began with 
10 min of  stretching and was conducted using the 
maximal heart rate index (HRmax) estimated by: 220-
age. First 2 weeks = 60–70% of  HRmax, 3rd to 12th 
weeks = 70–80% of  HRmax [24].  
Resistance exercise training
Patients in Group B were submitted to a 40 min session 
of  resistance training. The program began with 10 min 
of  stretching and was conducted with exercises done on 
nine resistance machines. The resistance machines used 
were: chest press, bicep curl, triceps extension, lower 
back, abdominals, leg press, leg curl and leg extension. 
Subjects performed three sets of  8–12 repetitions, with 
60 s of  rest between each set. Resistance was increased 
by five pounds after the subject was able to complete 
three sets of  eight repetitions on three consecutive 
days. Subjects were trained using between 60 and 80% 
of  their one maximal repetition weight (1-RM) [25].  
Statistical analysis
The mean values of  TNF- α, IL-6, IL-8, AST and ALT 
obtained before and after three months in both groups 
were compared using paired “t” test. Independent “t” 
test was used for the comparison between the two 
groups (P<0.05).
Results
The two groups were considered homogeneous 
regarding the Baseline descriptive
characteristics (Table 1). 
Table (1): comparison of  baseline characteristics between patients on mild and moderate exercise.
Variable
Mean + SD




Age (year) 50.87± 5.93 51.12± 5.58 P>0.05
Weight (Kg) 93.15 ± 6.51 92.43± 6.83 P>0.05
Height (cm) 168.21± 7.61 169.35 ± 6.54 P>0.05
TNF- α (pg/mL) 7.76 ± 1.84 7.89 ± 1.98 P>0.05
IL-6 (pg/mL) 8.42 ± 1.67 8.65 ± 1.67 P>0.05
IL-8 (pg/mL) 18.37 ± 3.78 18.62 ± 3.53 P>0.05
ALT (U/L) 38.98 ± 5.34 39.42 ± 5.87 P>0.05
AST (U/L) 47.65 ± 6.82 48.16 ± 6.78 P>0.05
TNF- α = tumor necrosis factor – alpha.                   IL-6 = Interleukin-6
IL-8= Interleukin-8                                                    ALT = Alanine aminotransferase                 
AST = Aspartate aminotransferase                               
There was a 78.39%, 57.67%, 49.83%, 20.12% and 
15.34 % reduction in mean values of  TNF- α, IL-6, 
IL-8, AST and ALT respectively in group (A) , however 
there was a  26.64%, 22.17%, 20.83%, 8.44% and 6.45 
% reduction in mean values of  TNF- α, IL-6, IL-8, AST 
and ALT respectively in group (B) at the end of  the 
study . The mean values of  TNF- α, IL-6, IL-8, AST 
and ALT were significantly decreased in both groups 
(Table 2 and 3). 
                   553African Health Sciences Vol 14 Issue 3, September 2014African Health Sciences Vol 14 Issue 3, September 2014
Table (2): Mean value and significance of  TNF- α, IL-6, IL-8, AST and ALT in group (A) before and 
after treatment.
Mean +SD T-value P-value
Before After
TNF- α (pg/mL) 7.76 ± 1.84 4.35 ± 1.21 5.35 P <0.05
IL-6 (pg/mL) 8.42 ± 1.67 5.34 ± 1.32 5.82 P <0.05
IL-8 (pg/mL) 18.37 ± 3.78 12.26 ± 2.91 7.84 P <0.05
ALT (U/L) 38.98 ± 5.34 32.45 ± 4.12 8.72 P <0.05
AST (U/L) 47.65 ± 6.82 41.31 ± 5.33 8.94 P <0.05
TNF- α = tumor necrosis factor – alpha.                   IL-6 = Interleukin-6
IL-8= Interleukin-8                                                    ALT = Alanine aminotransferase                 
AST = Aspartate aminotransferase                               
Table (3): Mean value and significance of  TNF- α, IL-6, IL-8, AST and ALT in group (B) before and 
after treatment.
Mean +SD T-value P-value
Before After
TNF- α (pg/mL) 7.89 ± 1.98 6.23 ± 1.71 3.15 P <0.05
IL-6 (pg/mL) 8.65 ± 1.67 7.08 ± 1.23 3.09 P <0.05
IL-8 (pg/mL) 18.62 ± 3.53 15.41 ± 3.18 4.97 P <0.05
ALT (U/L) 39.42 ± 5.87 36.35 ± 4.84 5.16 P <0.05
AST (U/L) 48.16 ± 6.78 45.24 ± 6.15 5.72 P <0.05
TNF- α = tumor necrosis factor – alpha.                   IL-6 = Interleukin-6
IL-8= Interleukin-8                                                    ALT = Alanine aminotransferase                 
AST = Aspartate aminotransferase                                 
Also, there were significant differences between mean levels of  the investigated parameters in group (A) and 
group (B) at the end of  the study (Table 4) (P<0.05).
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Table (4): Mean value and significance of  TNF- α, IL-6, IL-8, AST and ALT in group (A) and group (B) 
after treatment.
Mean +SD T-value P-value
Group (A) Group (B)
TNF- α (pg/mL) 4.35 ± 1.21 6.23 ± 1.71 3.34 P <0.05
IL-6 (pg/mL) 5.34 ± 1.32 7.08 ± 1.23 3.45 P <0.05
IL-8 (pg/mL) 12.26 ± 2.91 15.41 ± 3.18 3.82 P <0.05
ALT (U/L) 32.45 ± 4.12 36.35 ± 4.84 3.13 P <0.05
AST (U/L) 41.31 ± 5.33 45.24 ± 6.15 3.60 P <0.05
TNF- α = tumor necrosis factor – alpha.                   IL-6 = Interleukin-6
IL-8= Interleukin-8                                                    ALT = Alanine aminotransferase                 
AST = Aspartate aminotransferase                               
Discussion
Non-alcoholic steatohepatitis is a common liver dis-
ease that can progress to cirrhosis. Currently, there is 
no established treatment for this disease. So, there is an 
urgent need for efficient therapeutic options as there is 
still no approved medication. Moreover, the type, dose 
and intensity of  physical activity needed to obtain a sig-
nificant anti-inflammatory effect in this high-risk popu-
lation are largely unknown. Therefore, this study aimed 
to compare the impact of  aerobic and resisted exercise 
training on inflammatory cytokines and markers of  liver 
function in subjects with nonalcoholic steatohepatitis. 
The mean values of  TNF- α, IL-6, IL-8, AST and ALT 
were significantly decreased in group (A) received aero-
bic exercise training and group (B) received resisted ex-
ercise training  .Also; there was a significant difference 
between both groups after treatment , these findings are 
supported and agreed by several previous studies.
Zhang etal., conducted a study on 28 male Sprague-
Dawley strain rats were randomly assigned into four 
groups: standard diet without and with concurrent 
swimming exercise; and high-fat diet without and 
with concurrent swimming exercise for 12 weeks. 
The initial swimming duration of  30 minutes was 
progressively increased by 10 min·d−1 to 90 minutes 
by the end of  the fourth week, which then remained 
unchanged, findings revealed that long-term exercise 
carried out concurrently with consumption of  a high-
fat diet could alleviate high-fat diet-induced NASH 
which is attributable to the attenuation of  hepatic 
TNF-α overexpression and the upregulation of  
hepatic peroxisome proliferator activated receptor-
alpha (PPARα ) mRNA expression [26].  
Maintaining or increasing physical activity provides 
health benefits for patients with fatty liver, independent 
of  changes in weight [27].   Weight, blood biochemi-
cal data as aminotransferase, albumin, cholinesterase, 
total cholesterol and fasting blood glucose values were 
significantly decreased after a program of  restricted 
diet and exercise (walking or jogging) for a trial period 
of  3 months in a previous study on twenty-five obese 
patients with fatty liver [28]. Regular exercise was also 
associated with significantly greater ALT improvement 
and normalization. For instance, exercise is known to 
improve the sensitivity of  muscle mass to insulin [29].  
The potential mechanisms for the anti-inflammatory 
effect of  exercise include reduced percentage of  body 
fat and macrophage accumulation in adipose tissue, 
muscle-released interleukin-6 inhibition of  tumour 
necrosis factor-a, and the cholinergic anti-inflammatory 
pathway [30].  
Eighty-two patients were randomized into 4 groups: 
sedentary control (A) received low-intensity aerobic 
exercise, group (B) performed high-intensity aerobic, 
group (C) performed aerobic and resistance exercises 
and group (D) performed exercise (with the same 
caloric expenditure) for 12 months. Physical exercise in 
type 2 diabetic patients with the metabolic syndrome is 
associated with a significant reduction of  inflammatory 
and insulin resistance biomarkers, independent of  
weight loss. Long-term high-intensity (preferably 
mixed) training, in addition to daytime physical activity, 
is required to obtain a significant anti-inflammatory 
effect [31].   
It is possible that aerobic exercise decreases subclinical, 
chronic inflammation and improves endothelial function 
simply as a result of  reducing obesity (particularly 
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visceral obesity) and improving insulin sensitivity 
[32]. During regular aerobic exercise, skeletal muscle 
fibres inhibit the production of  the pro-inflammatory 
cytokine TNF-α and produce several anti-inflammatory 
cytokines (termed “myokines”) that may be involved in 
mediating the health-beneficial effects of  exercise [33]. 
Additionally, exercise training may reduce mononuclear 
cell production of  pro-inflammatory cytokines by 
reducing chronic oxidative stress [34].  Exercise has 
the potential to lower the inflammatory status by the 
reduction of  tumor necrosis factor (TNF-α) [35, 36].   
Exercise suppresses the production of  proinflammatory 
cytokines and enhances anti-inflammatory cytokines. 
Because proinflammatory cytokines, IL-6 and TNF-α, 
have cytotoxic actions, it can be proposed that regular 
exercise prevents further damage to insulin-producing 
β-cells by attenuating the production of  these cytokines 
[33, 37].  However, high-intensity exercise training 
program induced an improvement of  biomarkers of  
inflammation and insulin resistance, with a reduction 
of  IL-6, TNF- α and leptin and an increase of  IL-4 
and IL-10--- thus indicating that exercise has a full anti-
inflammatory effect [38].   
Conclusion 
Aerobic exercise training modulates inflammatory 
cytokine levels and markers of  liver function in patients 
with nonalcoholic steatohepatitis.
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